학술논문
104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07)
Document Type
Article
Author
Source
In: Journal of Neurology . (Journal of Neurology, May 2024, 271(5):2810-2823)
Subject
Language
English
ISSN
14321459
03405354
03405354